Devson Catalyst IPO (9-13 July) Analysis
- 16 hours ago
- 13 min read
IPO Analysis | BSE SME Platform | Book Built Offer (Fresh Issue + OFS) | Price Band: [TBD]
Based on Red Herring Prospectus dated July 1, 2026 | Industrial Catalysts, Adsorbents and Ceramic Balls | Wadhwan City, Surendranagar, Gujarat
STATUS: RHP FILED | Fresh Issue: up to 33,38,000 Shares | OFS: up to 2,50,000 Shares by Promoters | Price Band: [TBD] | Issue Opens: July 9, Closes July 13, 2026 | BSE SME Platform |
Devson Catalyst Limited (DCL) is a Wadhwan City, Surendranagar, Gujarat-based indigenous integrated manufacturer of industrial catalysts, adsorbents and ceramic balls. Formerly known as Devson Insulators Private Limited and then Devson Catalyst Private Limited, the company converted to a public limited company ahead of this IPO.
Its registered office and manufacturing facility is at Plot No. 213 to 218 and 233 to 237, Phase II, Ambawadi, GIDC, Wadhwancity, Surendranagar, Gujarat 363030. Its website is www.devsongroup.com. Its CIN is U20119GJ2004PLC044722. The four promoters are Prahladbhai Devjibhai Shiyaniya, Patel Savan Prahladbhai, Pratapbhai Devjibhai Siyania, and Patel Krishna Savanbhai.
Business model: DCL manufactures a comprehensive range of catalysts, adsorbents, and ceramic balls used in critical industrial process applications across the oil and gas refining, petrochemicals, steel, and fertilizer value chains.
The products are used in process vessels, reactors, and fixed-bed systems where precise chemical and physical performance characteristics are required. The company's existing facility at Wadhwan City, GIDC has an installed manufacturing capacity of approximately 6,205 MT per annum and uses modern equipment including Rotary Dryers, Band Dryer Cum Calciners, and Flash Calciners.
A new manufacturing unit is being established at Plot No. 259, GIDC Estate, Wadhwancity (3,223 sq. mtrs., 57-year lease from December 2025) using IPO proceeds.
Product range and raw materials: the company's products are manufactured using alumina-based materials (Aluminium Trihydrate, Pseudobohemite), zeolite and molecular sieve materials, metal oxides including Zinc Oxide, Titanium Dioxide, and related precursors, along with chemical binders and additives. Products are tailored to customer specifications covering parameters such as purity, chemical composition, mechanical strength, surface area, and pore structure, reflecting the precision-engineered nature of catalysts for specific industrial reactions.
Export presence: Devson has a meaningful and growing international footprint. Export revenue was Rs.2,059.82 lakhs (FY2026), Rs.1,328.49 lakhs (FY2025), and Rs.1,817.38 lakhs (FY2024), representing 37.29%, 25.12%, and 42.10% of revenue from operations respectively. The company exports to more than 19 countries including Egypt, Indonesia, Iraq, Italy, Kuwait, Malaysia, Qatar, Russia, Saudi Arabia, South Africa, UAE, Vietnam, Germany, USA, and others, indicating a genuinely diversified international customer base.
Entry barriers and competitive positioning: the industrial catalyst and adsorbent sector has significant barriers to entry, including stringent regulatory and technical prequalification requirements before a vendor can supply critical-process industries, order-by-order reapproval requirements involving audits and compliance documentation, and the high switching costs customers face when changing suppliers (testing, validation cycles, and internal approvals).
The company generates a significant portion of revenue through the regulated tendering process. The RHP explicitly notes that the company has no comparable listed peer group in India, reflecting the niche and differentiated nature of the business.
Key Basics
This is a 100% Book Built Offer comprising both a Fresh Issue and an Offer for Sale. The RHP is dated July 1, 2026. The Price Band has not been disclosed in this RHP and will be announced at least two working days before the Bid/Offer Opening Date. The Offer is made under Regulation 229(2) and 253(1) of SEBI ICDR Regulations. Six promoters and promoter group members are selling shares in the OFS at very low average acquisition costs (the highest WACA among OFS sellers is Rs.0.24 per share).
Document Type | Red Herring Prospectus (RHP) dated July 1, 2026. Price Band to be announced before Bid/Offer Opening Date. Issue opens July 9, closes July 13, 2026. |
Offer Structure | Fresh Issue of up to 33,38,000 Equity Shares + OFS of up to 2,50,000 Equity Shares by 6 Promoter/Promoter Group Selling Shareholders. Total Offer: up to 35,88,000 Equity Shares. |
Face Value | Rs.10 per Equity Share |
OFS Selling Shareholders | Prahladbhai Devjibhai Shiyaniya (64,369 shares, WACA Rs.0.24), Patel Savan Prahladbhai (40,637 shares, WACA Nil), Pratapbhai Devjibhai Siyania (82,737 shares, WACA Rs.0.14), Patel Krishna Savanbhai (10,241 shares, WACA Nil), Gayatriben Patel (9,753 shares, WACA Rs.0.04), Shiyania Gitaben P (42,263 shares, WACA Rs.0.01). Total OFS: 2,50,000 shares. |
Promoters | Prahladbhai Devjibhai Shiyaniya, Patel Savan Prahladbhai, Pratapbhai Devjibhai Siyania, and Patel Krishna Savanbhai. |
Eligibility | Regulation 229(2) and 253(1) of Chapter IX of SEBI ICDR Regulations 2018. |
Listing Exchange | SME Platform of BSE Limited (BSE SME). In-principle approval received April 28, 2026. Designated Stock Exchange: BSE. |
BRLM | JJ IPO Advisors Private Limited. Contact: Chetan Jagetiya. Email: info@jjipoadvisors.com |
Registrar | MUFG Intime India Private Limited (formerly Link Intime India Private Limited). Email: devsoncatalyst.smeipo@in.mpms.mufg.com |
Anchor Bidding | Wednesday, July 8, 2026. |
Bid/Offer Opens | Thursday, July 9, 2026. |
Bid/Offer Closes | Monday, July 13, 2026. |
Listed Industry Peers | None. The RHP explicitly states: 'Our Company does not have any peer group company for comparison with Industry Peer.' No listed comparable disclosed. |
OFS Seller Cost Context | The highest WACA among all six OFS sellers is Rs.0.24 per share. All OFS sellers are selling shares at a substantial premium to their near-zero cost of acquisition, a common characteristic of early-stage promoter share issuances. The Price Band will determine the exact premium multiple. |
The OFS proceeds go entirely to the Selling Shareholders. The Fresh Issue Net Proceeds are deployed across three objects: a new manufacturing facility (the dominant allocation), working capital, and general corporate purposes. The new unit at Plot 259 is the central growth investment funded by this IPO.
Object | Amount (Rs. Lakhs) | Details |
Capital Expenditure: Setting up New Manufacturing Unit at Plot 259, GIDC, Wadhwancity | 1,739.84 | Total project cost is Rs.1,934.42 lakhs: Land Rs.194.58 lakhs (already acquired via 57-year GIDC lease, funded from internal accruals), Building and civil works Rs.410.10 lakhs (quotation from M/s Shakti Construction dated May 29, 2026), Plant and machinery Rs.1,220.73 lakhs (including Batching Plant with Extruder, Flash Calciner, Turbo Spin Flash Calcination System, Band Dryer-cum-Calciner, Double Girder EOT Crane), and 350 KWp solar rooftop Rs.109.01 lakhs. No firm orders placed for plant and machinery as of RHP date. |
Funding Working Capital Requirements | 1,200.00 | Working capital to support FY2026-27 operations, with net working capital requirement projected to grow from Rs.2,122.69 lakhs (FY2026) to Rs.3,118.23 lakhs (FY2027) as trade receivables and inventories scale with anticipated revenue growth and the expanded facility. |
General Corporate Purposes | [TBD] | Residual from Fresh Issue Net Proceeds after quantified objects, capped at 15% of Fresh Issue proceeds or Rs.1,000 lakhs, whichever is lower. |
TOTAL IDENTIFIED FRESH ISSUE OBJECTS | 2,939.84 | 100% Fresh Issue net proceeds (excluding GCP). None of the Objects have been appraised by any bank or financial institution. Project cost for the new unit has been certified by Vishvakarma Consulting Services Private Limited, Chartered Engineer, dated June 9, 2026. |
The use of proceeds is coherent and operationally driven. The new manufacturing unit at Plot 259 addresses a genuine constraint: the RHP explicitly states that the proposed machinery (Batching Plant, Flash Calciner, etc.) cannot be installed at the existing facility due to space constraints.
The new unit's 3,223 sq. mtr. plot area is in addition to the existing 11,619 sq. mtr. facility, representing a meaningful capacity addition. The working capital allocation addresses the structurally growing receivables and inventory as the business scales. Land for the new facility has already been secured under a 57-year GIDC lease registered in December 2025.
Financial Performance
Note: All figures in Rs. lakhs unless stated. Financial periods: Fiscal 2026 (year ended March 31, 2026), Fiscal 2025 (year ended March 31, 2025), Fiscal 2024 (year ended March 31, 2024). Restated Financial Statements under Indian GAAP, audited by O.M.M.S. and Associates, Chartered Accountants (FRN 135149W). This is the standout financial profile of the current IPO review series: PAT grew 207% over two years, EBITDA margin expanded from 15.29% to 29.49%, and all three years show strongly positive operating cash flows.
Revenue, EBITDA, and Profitability
Metric | FY2026 (Rs. L) | FY2025 (Rs. L) | FY2024 (Rs. L) | |
Revenue from Operations | 5,577.59 | 5,319.21 | 4,346.99 | |
Revenue Growth % YoY | +4.86% | +22.37% | N/A | |
Export Revenue (Rs. Lakhs) | 2,059.82 | 1,328.49 | 1,817.38 | |
Export as % of Revenue | 37.29% | 25.12% | 42.10% | |
Other Income | 106.85 | 34.68 | 28.05 | |
Total Income | 5,684.44 | 5,353.89 | 4,375.04 | |
Cost of Material Consumed | 2,951.94 | 2,528.06 | 2,590.39 | |
Purchase of Stock in Trade | 248.22 | 835.62 | 177.39 | |
Change in Inventories | (483.34) | (67.48) | 102.50 | |
Employee Benefit Expenses | 434.80 | 385.62 | 304.90 | |
Finance Costs | 44.08 | 37.87 | 89.94 | |
Depreciation and Amortisation | 56.04 | 52.03 | 39.33 | |
Other Expenses | 749.51 | 544.21 | 502.72 | |
Total Expenses | 4,001.25 | 4,315.93 | 3,807.17 | |
Profit Before Tax | 1,683.19 | 1,037.96 | 567.87 | |
Tax Expenses (Net) | 431.10 | 270.73 | 160.03 | |
Profit After Tax | 1,252.09 | 767.23 | 407.84 | |
PAT Growth % YoY | +63.20% | +88.12% | N/A | |
PAT CAGR FY2024 to FY2026 | +207.01% (absolute) over 2 years | |||
EBITDA (Rs. Lakhs) | 1,676.46 | 1,093.17 | 669.08 | |
EBITDA Margin % (of Total Income) | 29.49% | 20.42% | 15.29% | |
EBITDA Growth FY2024 to FY2026 | +155.80% (absolute) over 2 years | |||
Net Profit Margin % (of Revenue) | 22.45% | 14.42% | 9.38% | |
Return on Equity (RoE) % | 45.97% | 44.76% | 36.20% | |
Return on Capital Employed (ROCE) % | 47.60% | 44.71% | 36.67% | |
Debt to Equity Ratio (times) | 0.07x | 0.13x | 0.33x | |
Current Ratio (times) | 4.18x | 3.26x | 1.81x | |
Debt Service Coverage Ratio (times) | 5.63x | 7.72x | 95.30x | |
Net Worth (Rs. Lakhs) | 3,349.82 | 2,097.73 | 1,330.50 | |
Basic and Diluted EPS (Rs.) | 12.22 | 7.49 | 3.98 | |
The financial profile of Devson Catalyst is exceptional across every metric reviewed in this series. Revenue grew at a CAGR of 13.21% over the two-year period, but profitability has dramatically outpaced revenue growth. EBITDA grew 155.80% while revenue grew only 28.31%, reflecting enormous operating leverage as the high fixed-cost catalyst manufacturing business scaled its throughput.
EBITDA margin nearly doubled from 15.29% to 29.49% in two years, and PAT margin expanded from 9.38% to 22.45%. RoCE of 47.60% and RoE of 45.97% in FY2026 are among the highest seen across all companies reviewed in this series.
Perhaps most notably, the debt-to-equity ratio declined from 0.33x (FY2024) to just 0.07x (FY2026), meaning the company has been rapidly deleveraging through retained earnings. Finance costs of just Rs.44.08 lakhs in FY2026 on a net worth of Rs.3,349.82 lakhs indicate near-complete financial independence from debt.
The current ratio has expanded from 1.81x to 4.18x, suggesting substantial and growing liquidity. These metrics collectively describe a business that has achieved strong profitability momentum while simultaneously strengthening its financial position.
A note on revenue composition: Stock-in-Trade purchases swung significantly, from Rs.177.39 lakhs (FY2024) to Rs.835.62 lakhs (FY2025) and back to Rs.248.22 lakhs (FY2026). This volatility likely reflects periodic sourcing of certain products from third parties to fulfil specific customer orders, a trading component alongside the company's primary manufacturing operations. Investors should note that total cost of goods (material consumed + stock in trade + inventory change) as a percentage of revenue from operations varied across the three years.
Balance Sheet and Cash Flow
Item | FY2026 (Rs. L) | FY2025 (Rs. L) | FY2024 (Rs. L) |
Equity Share Capital | 1,025.00 | 25.00 | 25.00 |
Reserves and Surplus | 2,324.82 | 2,072.73 | 1,305.50 |
Total Net Worth / Shareholders Funds | 3,349.82 | 2,097.73 | 1,330.50 |
Long-Term Borrowings | 89.25 | 8.87 | 18.75 |
Short-Term Borrowings | 160.86 | 269.59 | 416.63 |
Total Borrowings | 250.11 | 278.46 | 435.38 |
Trade Payables | 328.81 | 216.79 | 167.63 |
Total Assets | 4,162.76 | 2,737.65 | 2,148.68 |
Property, Plant and Equipment (Net) | 1,298.72 | 798.49 | 796.39 |
Inventories | 774.77 | 277.17 | 213.84 |
Trade Receivables | 1,675.32 | 1,266.56 | 799.55 |
Cash and Cash Equivalents | 216.50 | 126.38 | 115.93 |
Net Cash from Operating Activities | 455.64 | 450.07 | 20.78 |
Net Cash from Investing Activities | (294.90) | (247.43) | (70.62) |
Net Cash from Financing Activities | (70.62) | (192.19) | 262.36 |
The share capital jump from Rs.25 lakhs to Rs.1,025 lakhs in FY2026 reflects a large bonus share issuance that expanded the equity base ahead of the IPO. This is a standard pre-IPO structuring step to create a larger share count at face value, and all EPS figures are adjusted retrospectively for this change. Despite the larger share count, net worth still grew from Rs.2,097.73 lakhs (FY2025) to Rs.3,349.82 lakhs (FY2026) driven by retained earnings.
Operating cash flows have been consistently positive across all three years (Rs.20.78 lakhs in FY2024, Rs.450.07 lakhs in FY2025, Rs.455.64 lakhs in FY2026), confirming strong earnings quality. Trade receivables have grown proportionally with revenue (from Rs.799.55 lakhs to Rs.1,675.32 lakhs over two years), representing approximately 30 days of revenue outstanding, a healthy receivables cycle for a B2B industrial manufacturer.
Inventories have also grown, particularly in FY2026 (from Rs.277.17 to Rs.774.77 lakhs), likely reflecting strategic stocking of raw materials to support production scale-up and maintain supply chain buffer.
How Does It Compare to Peers?
This section is unique in this series: Devson Catalyst's RHP explicitly discloses that the company has no comparable listed peer group in India. The company operates in the niche industrial catalyst and adsorbent manufacturing segment, and the RHP states directly: 'Our Company does not have any peer group company for comparison with Industry Peer.'
No P/E, RoNW, or NAV comparison table has been provided. This absence of peer benchmarking is both a reflection of the genuine differentiation of the business and a limitation on valuation anchoring for investors.
Context | Observation |
Listed Indian Peers | None disclosed. Company explicitly states no comparable listed peer exists in India. |
Global Context | International catalysts companies include W.R. Grace, Clariant, BASF Catalysts, and Albemarle, all significantly larger global players. These are not disclosed as peers in the RHP. |
Valuation Approach | With no peer P/E to anchor against, investors must value DCL on an absolute basis: its own earnings trajectory, asset quality, and sectoral growth prospects. At the Price Band (TBD), the prospective P/E will be calculated against FY2026 EPS of Rs.12.22 or the 3-year weighted average EPS. |
Why No Peers? | The company occupies a niche segment combining catalyst chemistry, adsorbent manufacturing, and ceramic ball production with both domestic and export sales. No listed Indian SME or main board company operates an identical or closely comparable business. |
Financial Quality Relative Benchmark | Compared to all other SME IPOs reviewed in this series: RoCE of 47.60% and EBITDA margin of 29.49% in FY2026 are among the highest seen. Three-year consecutive positive OCF is also rare in this cohort. |
The absence of a peer group makes valuation entirely dependent on investor assessment of absolute metrics. Using FY2026 EPS of Rs.12.22 as the baseline, a P/E of 15x would imply a price of approximately Rs.183, while 25x would imply Rs.306, and 35x would imply Rs.428. The actual Price Band, when disclosed, should be evaluated against these reference points and against the company's own RoCE, margin, and growth trajectory rather than any peer comparison table.
Key Risks
l Price Band has not been disclosed in this RHP: the Price Band will be announced at least two working days before the Bid/Offer Opening Date. Investors are evaluating this opportunity without knowing the issue price, which significantly limits the ability to assess valuation at the time of reading this analysis. The P/E multiple at which investors will be subscribing is unknown until the Price Band is confirmed.
l OFS sellers have near-zero cost of acquisition (highest WACA Rs.0.24 per share) and are selling at potentially very large premiums: all six OFS sellers are promoters or promoter group members selling shares acquired at costs ranging from Rs.0.01 to Rs.0.24 per share. The Issue Price, even at a modest absolute level, represents hundreds of times their acquisition cost. While this is common in long-standing family businesses, it means promoters receive very large returns from the OFS component, which investors should factor into their assessment of promoter alignment post-IPO.
l No comparable listed peer group limits valuation benchmarking: the RHP explicitly acknowledges there is no comparable listed peer for comparison, meaning investors have no public market P/E reference against which to assess whether the eventual Issue Price represents fair value. Valuation must be conducted on an absolute basis using DCL's own financial metrics, creating higher analytical uncertainty than typical SME IPOs.
l All manufacturing concentrated at two proximate Gujarat locations: both the existing facility (Plot 213-218/233-237) and the proposed new unit (Plot 259) are within the same GIDC Estate in Wadhwancity, Surendranagar, Gujarat. Any regional disruption, regulatory action, infrastructure failure, or natural calamity affecting this industrial estate would impair the entirety of the company's manufacturing operations simultaneously.
l Revenue from operations growth was modest in FY2026 (+4.86%) despite the exceptional profit growth: while PAT and margins improved dramatically in FY2026, revenue grew only 4.86% on top of FY2025's strong 22.37% growth. The profit improvement in FY2026 is partly attributable to a large reduction in stock-in-trade purchases (from Rs.835.62 lakhs to Rs.248.22 lakhs) and inventory build (Rs.483.34 lakhs favourable inventory swing). Investors should assess whether the FY2026 margin expansion reflects structural operational improvement or a more favourable year for product mix and procurement.
l New manufacturing unit has no purchase orders placed for plant and machinery: the Rs.1,220.73 lakh plant and machinery component of the capex plan is based on quotations only, with no firm orders placed as of the RHP date. Final vendor selection, specifications, and prices may change. The entire new unit project has not been appraised by any bank or financial institution.
l End-market concentration in oil and gas refining, petrochemicals, steel, and fertilizers: all four sectors are capital-intensive and cyclical, and catalyst demand is tied to their operating rates, plant utilisation, and turnaround/replacement cycles. Any downturn in these industries, or deferral of plant shutdowns and turnarounds, directly reduces catalyst and adsorbent demand.
l Export revenue volatility: export revenue ranged from 25.12% to 42.10% of revenue across the three years. This variability reflects the order-driven, tender-based nature of international sales rather than a recurring subscription model, creating quarter-to-quarter and year-to-year revenue unpredictability in the export segment.
l Statutory compliance history: the RHP discloses 12 instances of TDS payment delays in FY2026 (vs. 2 in FY2025 and 1 in FY2024), a concerning trend of increasing compliance lapses even as the company prepares for a public listing. While all dues have been paid and no outstanding liabilities exist as of the RHP date, the frequency increase warrants attention.
l Raw material price and availability risk: alumina-based materials, zeolites, metal oxides, and specialty chemicals are the primary inputs. Prices for these can be volatile, and supply can be constrained by commodity cycles, import lead times, and port/logistics disruptions. The company operates in a sector where selling prices may be fixed under tenders, limiting the ability to pass through cost increases immediately.
Positives
l PAT grew 207% and EBITDA grew 156% over two years: these are among the strongest two-year profit and EBITDA growth rates seen in any company reviewed in this series. The compound improvement in profitability from Rs.407.84 lakhs (FY2024) to Rs.1,252.09 lakhs (FY2026) demonstrates accelerating earnings momentum.
l EBITDA margin of 29.49% (FY2026) is industry-leading for a specialty chemicals manufacturer: margins nearly doubled from 15.29% (FY2024) to 29.49% (FY2026), reflecting the high value-added nature of catalyst and adsorbent products and the operating leverage of the manufacturing model. This level of EBITDA margin is uncommon in manufacturing SMEs.
l Near-zero leverage with debt-to-equity of 0.07x: total borrowings of just Rs.250.11 lakhs against net worth of Rs.3,349.82 lakhs represent an exceptionally clean balance sheet. With finance costs of only Rs.44.08 lakhs on FY2026 revenue of Rs.5,577.59 lakhs, the company has essentially no financial leverage risk and retains full earnings power for reinvestment.
l Consistent positive operating cash flows across all three years: Rs.20.78 lakhs (FY2024), Rs.450.07 lakhs (FY2025), and Rs.455.64 lakhs (FY2026) demonstrate that reported profitability is backed by genuine cash generation, an important quality marker in the SME IPO space where many issuers show positive PAT alongside negative or near-zero operating cash flows.
l Export presence across 19 countries provides genuine geographic diversification and international quality validation: achieving and maintaining supplier approvals with customers in oil and gas refineries in the Middle East, Europe, Southeast Asia, and the Americas requires meeting international quality standards, and the company's sustained multi-country export revenue validates its product quality credentials beyond the domestic market.
l Significant entry barriers protect the competitive position: vendor prequalification requirements, order-by-order reapprovals, technical validation cycles, and customer switching costs create a structural moat that limits the competitive threat from new entrants. The company has been operating since 2004, giving it a 20-year track record of approvals and relationships in a sector where institutional trust is a genuine and difficult-to-replicate asset.
l New manufacturing unit at an already-leased, GIDC-allocated site removes a key execution risk: the 57-year GIDC lease for Plot 259 was registered in December 2025, meaning the land component of the expansion is secured. The building and civil works quotation is also received, with only the plant and machinery procurement remaining to be finalised. This reduces the risk of land or site availability delays often associated with greenfield manufacturing expansions.



Comments